DNA and Cell Biology · 2009 · 43 citations · 10 references
Life SciencesOncologyToxicologyApoptosisCancer PharmacologyMolecular OncologyApoptosis In CancerDna Damage-induced ApoptosisMalignant NeoplasmsAnticancer ActivityApoptosis-related Dna DamageComet Assay ScoringDna Damage Induction
Protoapigenone, isolated from the native fern plant Thelypteris torresiana, has anticancer activity against some cancer cells. However, the toxicological mechanism for protoapigenone is still unknown. Here, we investigated the anticancer effect of protoapigenone on human lung cancer cell lines. The comet assay showed that DNA damage induced by protoapigenone is dose-dependent. Trypan blue exclusion showed that the cell killing by protoapigenone is both time and dose dependent. The IC(50) of protoapigenone for 12, 24, and 48 h in H1299 cells is 6.11, 2.74, and 1.49 microM, respectively. Flow cytometry showed cell cycle perturbation such as sub-G(1) accumulation (at 1.57 microM for 48 h and at 3.57 microM for 12 and 24 h) and G(2)/M arrest (at 3.57 microM for 12 and 24 h) for protoapigenone. The sub-G(1) accumulation phenomena in the 3.57 microM for 24 h sample were shown to be apoptosis using Annexin V-immunofluorescence/propidium iodide staining. These results suggest protoapigenone is a potential chemotherapeutic agent for lung cancers.
10
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2008 · 10.2K citations · Full text
Hsueh-Ling Chang, Yang‐Chang Wu, Jinu‐Huang Su et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 70 citations
Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo
Hsueh-Ling Chang, Jinu‐Huang Su, Yao‐Tsung Yeh et al. · Cancer Letters · 2008 · 56 citations
Medicine, Oncology, Pharmacology +13